A hepatitis C screening is a blood test that checks whether you’ve ever been infected with the hepatitis C virus (HCV). The CDC recommends that every adult aged 18 and older get screened at least once in their lifetime, and that all pregnant people get screened during each pregnancy. The process typically starts with a simple antibody test and, if needed, a follow-up test to confirm whether the virus is still active in your body.
Who Should Get Screened
Universal screening applies to all adults 18 and older. You only need the test once unless you have ongoing risk factors. Pregnant people should be screened at the start of prenatal care with every pregnancy, not just the first.
If you currently inject drugs and share needles or preparation equipment, or if you receive maintenance hemodialysis, the CDC recommends routine periodic testing rather than a one-time screen. Previous guidelines took a risk-based approach, focusing on people born between 1945 and 1965, but the current recommendation is universal for all adults regardless of risk factors.
How the Test Works
Screening follows a two-step process. The first step is an HCV antibody test. Your body produces antibodies as a defense when it encounters the virus, and this test checks your blood for those antibodies. A negative result means you are not currently infected. A positive (reactive) result means you were infected at some point, but it doesn’t tell you whether the virus is still present.
If the antibody test comes back positive, the lab will automatically run a second test on the same blood sample. This follow-up is called a nucleic acid test (NAT) for HCV RNA, and it looks for the actual virus in your blood rather than your immune system’s response to it. A positive RNA result confirms a current, active infection. A negative RNA result means the virus was cleared, either by your immune system on its own or through prior treatment.
One important exception: if you were potentially exposed to hepatitis C within the past six months, your doctor should skip the antibody test and go straight to the RNA test. That’s because antibodies can take two to six months to become detectable after exposure. The virus itself, by contrast, shows up in blood within days to two weeks. During that gap, called the window period, an antibody test could miss an active infection.
Rapid Tests vs. Lab Tests
Most screenings use a standard lab-based blood draw, but rapid point-of-care tests are also available. These use a fingerstick rather than a full blood draw. A healthcare worker pricks your finger with a small lancet, collects a drop of blood with a tiny loop, and applies it to a test device. Results are ready in 20 to 40 minutes.
Rapid tests detect antibodies only. If a rapid test comes back positive, you’ll still need a lab-based RNA test to confirm whether the infection is active. The standard lab antibody tests are highly accurate, with specificity above 99%, meaning false positives are rare.
What Your Results Mean
There are three main outcomes from the screening process:
- Antibody negative: No infection detected. No further testing is needed unless you have a recent exposure within the past six months or ongoing risk factors.
- Antibody positive, RNA negative: You were infected at some point, but the virus is no longer in your body. This can happen if your immune system cleared the infection on its own (which occurs in roughly 15 to 25 percent of cases) or if you were previously treated and cured. No further action is needed in most cases. Your antibody test will always come back positive for the rest of your life, even though you’re no longer infected.
- Antibody positive, RNA positive: You have an active hepatitis C infection that needs treatment.
In rare cases, a positive antibody result is a biologic false positive, meaning the test reacted to something other than actual HCV antibodies. If there’s reason to question the result and the RNA test is negative, a doctor can order a second, different antibody test to sort it out.
What Happens After a Positive Result
If your RNA test confirms active hepatitis C, the next steps focus on understanding how the virus has affected your liver and which strain of the virus you carry. You’ll typically be referred to a hepatologist (liver specialist) or infectious disease specialist.
A key part of the evaluation is checking for liver scarring, called fibrosis. This is often done with noninvasive imaging rather than a biopsy. Magnetic resonance elastography uses sound waves and MRI technology to create a map of stiff areas in the liver, where stiffness indicates scarring. Transient elastography is another painless imaging option. You’ll also have blood work to identify your specific hepatitis C genotype, which helps determine the best treatment approach.
The good news is that hepatitis C is now curable in most cases with antiviral medications taken for 8 to 12 weeks. The specific treatment and duration depend on the genotype, the extent of liver damage, and whether you’ve been treated before.
Cost and Insurance Coverage
Hepatitis C screening is classified as a preventive service under the Affordable Care Act. The U.S. Preventive Services Task Force gave it a Grade B recommendation for adults aged 18 to 79, which triggers a coverage requirement. Non-grandfathered private insurance plans, Medicare, and Medicaid expansion plans cover the screening with no copay or cost-sharing. Traditional Medicaid coverage for adults varies by state, though children are generally covered under the Early and Periodic Screening, Diagnostic, and Treatment benefit.
If you’re uninsured, many community health centers, local health departments, and harm reduction programs offer free or low-cost hepatitis C testing, often using rapid fingerstick tests.